Alignment Isn’t a Buzzword—It’s Your Competitive Advantage
- Sarah Sink

- Sep 25
- 3 min read
In this industry, we talk a lot about timelines, capabilities, and proposals. But you know what often makes or breaks a partnership before the tech transfer even starts?
Alignment. And it starts at the top.
That might sound obvious, but when you’ve sat on both sides of the CDMO table, on the biotech CMC side and in business development, you start to see how often alignment is assumed rather than confirmed.
Leadership buy-in, functional cohesion, and shared expectations aren’t nice-to-haves. They’re the difference between a clear, confident partnership… and one that stalls out before kickoff.
What Alignment Looks Like for Biotech Teams
For sponsors, alignment is more than having a slide deck everyone agrees on. It means the CMC lead, the clinical lead, the regulatory lead, and executive sponsor are aligned on:
What matters most right now (speed, data, cost, flexibility)
Where the risk tolerance actually lies
What the team is (and isn’t) ready to commit to
I’ve seen programs delayed not because of technical gaps, but because internal misalignment forced rework midstream. The CDMO doesn’t just need your molecule, they need your clarity.
When leaders don’t explicitly align before external conversations begin, it shows. Functional leaders send mixed messages. Scope shifts halfway through the proposal. And credibility starts to erode.
What Alignment Looks Like for CDMO Business Development
From the CDMO side, alignment starts with how we show up for that first call.
Are we unified on how we qualify opportunities?
Do our SMEs and project teams understand the value prop we’re presenting?
Have commercial and operations aligned on what’s realistic to propose?
If the BD lead is promising flexibility while the site is firm on fixed assets and timelines, it sets the stage for internal friction and external mistrust.
Internal misalignment slows down proposals, introduces handoff confusion, and creates tension between functions that are supposed to be pulling together.
When BD has a clear, consistent approach and senior leadership backs that structure, it creates a better experience for the sponsor and the internal team supporting the deal.
What We All Lose Without It
Without top-down alignment:
Biotech sponsors burn time re-negotiating scope or recalibrating internal decisions under pressure.
CDMO teams scramble to rework timelines, chase down approvals, and patch over mixed messaging.
Programs stall, teams lose credibility, and trust suffers.
Alignment is rarely about a single decision.
It's about the posture of the team. And posture is shaped by leadership on both sides of the table.
So Where Do You Start?
For biotech teams: Start with an internal alignment session before outreach. Ask tough questions. Define what success really means for your program. And make sure your internal story makes sense before you try to tell it externally.
For CDMO teams: Refine your internal deal review process. Make sure commercial and technical leaders are aligned on your ideal customer profile, proposal structure, and project fit before the next intro call hits the calendar.
If you're looking for more structure in how to do that, I created two courses that can help:
How to Get Internal Alignment Before Engaging a CDMO - designed for biotech program leaders and CMC teams
Ask Smarter, Close Sooner - built for CDMO BD professionals looking to qualify smarter and align faster internally.
Each course gives you a repeatable framework to reduce confusion, move faster, and build trust across the table.
Final Thought: No One Has Time to Backpedal
The truth is, no one has time to walk things back.
Not in this market. Not with limited funding. Not with critical milestones on the line.
When leadership sets the tone early and when alignment starts at the top, teams move faster, vendors perform better, and partnerships grow stronger.
That first call shouldn’t be the start of discovery. It should be the continuation of clarity.
For more insights and personalized support in navigating the biotech-CDMO landscape, visit my website: www.yourpharmagirl.com and follow Your Pharma Girl on LinkedIn. Whether you need strategic guidance, tailored BD solutions, or expert advice on building lasting partnerships, I'm here to help you and your team succeed at every stage of development.
.png)



Comments